Journal
FUTURE VIROLOGY
Volume 17, Issue 6, Pages 355-358Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/fvl-2022-0023
Keywords
artificial intelligence; adolescents; youths; HIV prevention; infectious diseases; men who have sex with men (MSM); resource-limited settings; sexually transmitted infections; transgender women (TGW)
Categories
Funding
- GSK ViiV
- Sysmex Corporation
- Cepheid
- DCH Auriga (LFAsia)
- Abbott
- TREAT Asia
- Oxford Immunotec
- Atlanta
- Viatris
- Government Pharmaceutical Organization (GPO)
- Thailand Convention and Exhibition Bureau (TCEB)
Ask authors/readers for more resources
HIV-NAT has been organizing the Bangkok International Symposium on HIV Medicine annually since 1998, providing the latest advances in HIV medicine to healthcare professionals in the Asia-Pacific region. The 24th symposium, held virtually in 2022, consisted of 27 sessions over 3 days with presentations by experts from Australia, India, Malaysia, the Netherlands, etc. Topics such as the impact of COVID-19 and artificial intelligence on healthcare were included.
HIV-NAT has held the Bangkok International Symposium on HIV Medicine annually since 1998. It provides the latest advances in HIV medicine to professional healthcare workers in the Asia-Pacific region. This year's symposium (the 24th) was held virtually, from 19 to 21 January 2022. There were a total of 27 sessions divided over 3 days. The Symposium started in the afternoon following industrial symposia and ended at 18:00. Various topics were presented by experts from Australia, India, Malaysia, The Netherlands, Singapore, Switzerland, Thailand, UK and USA. COVID-19 has changed healthcare delivery and artificial intelligence is changing medical practice so sessions on these topics were included in the symposium.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
